STARTSEITE
Impressum
Datenschutz
  
 
  SPOT ON

Sofosbuvir (SOVALDI) for hepatitis C - progress with insufficient data

 
  NEW ON THE MARKET

PDE5 inhibitor No 4: Avanafil (SPEDRA) against erectile dysfunction

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

Renal denvervation for refractory hypertension - not outside clinical trials

 
  REVIEW
 

Tick-borne encephalitis (I)

 
  a-t READER'S QUESTIONS AND COMMENTS
 

Antidiarrheal racecadotril (TIORFAN, VAPRINO)

 
  IN BRIEF
 

St. John's wort - pregnant despite IMPLANON

Drug advertisement - is it enough to be a little critical?

Level of phenylephrine increased fourfold in combination with paracetamol

 
  CURRENT ADR NETWORK REPORT

Liver injury with pregabalin (LYRICA)

 
  SIDE EFFECTS
 

Macrolides: a risk factor for hypertrophic pyloric stenosis

 
  e a-t IN INTERNET
 

Sofosbuvir (SOVALDI) against chronic hepatitis C

 

© arznei-telegramm 4/2014